RWM Asset Management »

Cadrenal Therapeutics shares owned by RWM Asset Management

Quarter-by-quarter ownership of Cadrenal Therapeutics (CVKD) shares owned by RWM Asset Management from 13F filings

Historical chart of RWM Asset Management investment in Cadrenal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cadrenal Therapeutics held by RWM Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cadrenal Therapeutics by RWM Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.0k 200 5.12

More positions owned by RWM Asset Management

J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Vanguard Index Fds Growth Etf (VUG)
Dimensional Etf Trust Us Large Cap Val (DFLV)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Dimensional Etf Trust World Ex Us Core (DFAX)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Virtus Etf Tr Ii Seix Sr Ln Etf (SEIX)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Microsoft Corporation (MSFT)
J P Morgan Exchange Traded F Intl Bd Opp Etf (JPIB)
Tesla Motors (TSLA)
Morgan Stanley Etf Trust Eaton Vance Tota (EVTR)

View all positions for RWM Asset Management

Top funds holding Cadrenal Therapeutics

Vanguard Group
Vanguard Capital Management
Geode Capital Management
Vanguard Fiduciary Trust
BlackRock
Cygnus Capital Advisors
Tower Research Capital
Advisor Group Holdings
RWM Asset Management
Rockefeller Capital Management
Morgan Stanley
Wells Fargo & Company
Archer Investment Corp
IFP Advisors
UBS Group

View all funds holding Cadrenal Therapeutics